ArticleFrontiers in pharmacology2025

An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib.

Wenjuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.